THE IMPACT OF COVID-19 PANDEMIC IN THE HEMOPHILIA COMMUNITY
Cedric Hermans, Alain Weill and Glenn F Pierce have published an article on the impact of COVID-19 pandemic in the hemophilia community (Haemophilia 2020 Apr 4. [Epub ahead of print]). The editorial focuses on the COVID-19 (SARS-COV-2) pandemic as a new global challenge for the hemophilia community. At present, they report, it is impossible to […]
Statement on the second meeting of the International Health Regulations Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)
The second meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the outbreak of novel coronavirus 2019 took place on Thursday, 30 January 2020. China quickly identified the virus and shared its sequence, so that other countries are now able to diagnose it quickly and protect […]
Transmission of 2019-nCoV Infection from asymptomatic contacts in Europe and USA
Testo abstract:Coronavirus (2019-nCoV) from Wuhan is raising concerns in the health care community as the virus is spreading around the world. After being identified in late December 2019, the number of cases of Coronavirus (2019-nCoV) infections imported from China into other countries is increasing and its epidemiology is changing daily basis. In detail, in the […]
New physiotherapy concepts in hemophilia
Until the ’70s, hemophiliacs did not have great means and opportunities to improve the quality of life, they lived in a voluntary “segregation” due to a progressive disability, lacking therapeutic and rehabilitative supports properly for recovering physical activity . Subsequently, replacement therapy was developed with concentrates of the coagulation factors of which they were deficient […]
Physical exercise and rehabilitation in hemophilia
Physical exercise Physical exercise in patients with hemophilia (PWH) currently is used to heal faster after bleeding and to restore muscle-joint function in subjects with chronic arthropathy. Aquatic, stretching, proprioceptive and aerobic exercises are the most usual in PWH A and B of any severity. A Cochraine Database Systematic Review published in 2016 analyzed randomized […]
Bleeding and liver transplantation outcomes in haemophilia
Abstract BACKGROUND: Hepatitis C is the major cause of end-stage liver disease and the major indication for orthotopic liver transplantation (OLTx) in individuals with haemophilia. AIM: To assess the epidemiology and outcomes of OLTx in U.S. haemophilia patients. METHODS: We investigated haemophilia liver transplant recipients between 1993 and 2012, using the Nationwide Inpatient Sample, identified […]
Early start of the West Nile fever transmission season 2018 in Europe
In Europe, surveillance indicates that the 2018 West Nile fever transmission season started earlier than in previous years and with a steeper increase of locally-acquired human infections. Between 2014 and 2017, European Union/European Economic Area (EU/EEA) and EU enlargement countries notified five to 25 cases in weeks 25 to 31 compared with 168 cases in […]
12 June 2020
Emerging viral diseases and infectious disease risks
New pathogens and antimicrobial-resistant forms of older pathogens continue to emerge, some with the potential for rapid, global spread and high morbidity and mortality. Pathogens can emerge either through introduction into a new population or when the interaction with the vector changes; emergence is also influenced by microbiological adaptation and change, global travel patterns, domestic […]
23 April 2020
HEMOPHILIA AND SARS-COV-2 INFECTION
In January the SARS-COV-2 infection exploded in the chinese city of Wuhan and spread worldwide. At the moment there are no news on the impact in people with hemophilia. In the letter to the editor recently published (Cui Dongyan et al. Haemophilia. 2020 Apr 1. doi: 10.1111/hae.14000. [Epub ahead of print]) the authors report on […]
17 January 2018
Epidemiological characteristics of human prion diseases
In the absence of specific therapies for human prion diseases, which are frequently associated with neurodegenerative disorders with fatal outcome, only an active surveillance can be used to monitor and prevent the transmission of such diseases. For this reason, starting from 1993, surveillance systems have been established in many countries. Moreover, there is urgent need […]
12 June 2020
Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016
Prevalence, incidence and residual risk of HIV, HCV and HBV are critical indicators of the safety of the blood supply. The American Red Cross routinely monitors these markers. Herein the results of testing over 58 million donations from 2007 to 2016 are reported. The prevalence and incidence of these infections has declined or remained essentially […]
27 January 2020
DAMOCTOCOG ALFA PEGOL: A REVIEW IN HAEMOPHILIA A
Damoctocog alfa pegol (Jivi®) is approved in the USA, EU, Japan and Canada for the treatment and prophylaxis of previously treated patients aged ≥ 12 years with haemophilia A. Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered recombinant factor VIII (rFVIII) product with a longer terminal half-life than non-PEGylated FVIII […]